Mesa Laboratories Inc: (NASD: MLAB)
$54.89
0.64 (1.18%)
Volume 42,466
May 17 04:00 PM ET
Zacks Rank: NA 
| |
Income Statements
Annual Income Statement
Fiscal Year End for MESA LABS INC falls in the month of March .
All items in Millions except EPS data.
| 03/31/13 | 03/31/12 | 03/31/11 | 03/31/10 | 03/31/09 | |
|---|---|---|---|---|---|
| Sales | NA | 40 | 33 | 22 | 22 |
| Cost Of Goods | NA | 16 | 13 | 9 | 8 |
| Gross Profit | NA | 24 | 20 | 13 | 14 |
| Selling & Adminstrative & Depr. & Amort Expenses | 0 | 11 | 10 | 6 | 6 |
| Income After Depreciation & Amortization | 0 | 12 | 10 | 7 | 8 |
| Non-Operating Income | NA | -0 | -0 | 0 | 0 |
| Interest Expense | NA | 0 | 0 | 0 | 0 |
| Pretax Income | NA | 12 | 10 | 7 | 8 |
| Income Taxes | NA | 4 | 4 | 3 | 3 |
| Minority Interest | NA | 0 | 0 | 0 | 0 |
| Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
| Other Income/Charges | NA | 0 | 0 | 0 | 0 |
| Income From Cont. Operations | NA | 8 | 6 | 5 | 5 |
| Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
| Net Income | NA | 8 | 6 | 5 | 5 |
| Depreciation Footnote | 03/31/13 | 03/31/12 | 03/31/11 | 03/31/10 | 03/31/09 |
|---|---|---|---|---|---|
| Income Before Depreciation & Amortization | 0 | 15 | 12 | 8 | 8 |
| Depreciation & Amortization (Cash Flow) | NA | 2 | 2 | 1 | 1 |
| Income After Depreciation & Amortization | 0 | 12 | 10 | 7 | 8 |
| Earnings Per Share Data | 03/31/13 | 03/31/12 | 03/31/11 | 03/31/10 | 03/31/09 |
|---|---|---|---|---|---|
| Average Shares | NA | 3.46 | 3.33 | 3.29 | 3.24 |
| Diluted EPS Before Non-Recurring Items | NA | 2.63 | 2.08 | 1.45 | 1.48 |
| Diluted Net EPS | NA | 2.29 | 1.86 | 1.45 | 1.48 |
Quarterly Income Statement
Fiscal year end for MESA LABS INC falls in the month of March .
All items in Millions except EPS data.
| 03/31/13 | 12/31/12 | 09/30/12 | 06/30/12 | 03/31/12 | |
|---|---|---|---|---|---|
| Sales | NA | 11.36 | 11.71 | 10.56 | 10.52 |
| Cost Of Goods | NA | 4.41 | 4.45 | 4.10 | 5.72 |
| Gross Profit | NA | 6.94 | 7.24 | 6.45 | 6.48 |
| SG&A, R&D, and Dept/Amort Expenses | 0.00 | 4.48 | 3.75 | 3.23 | 3.14 |
| Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.46 | 3.49 | 3.22 | 3.34 |
| Non-Operating Income | NA | -0.03 | -0.03 | -0.03 | -0.01 |
| Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Pretax Income | NA | 2.42 | 3.45 | 3.18 | 3.33 |
| Income Taxes | NA | 0.88 | 1.20 | 1.08 | 1.13 |
| Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cont. Operations | NA | 1.54 | 2.25 | 2.10 | 2.20 |
| Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | NA | 1.54 | 2.25 | 2.10 | 2.20 |
| Earnings Per Share Data | 03/31/13 | 12/31/12 | 09/30/12 | 06/30/12 | 03/31/12 |
|---|---|---|---|---|---|
| Average Shares | NA | 3.54 | 3.54 | 3.54 | 3.53 |
| Diluted EPS Before Non-Recurring Items | NA | 0.56 | 0.76 | 0.70 | 0.76 |
| Diluted Net EPS | NA | 0.44 | 0.64 | 0.59 | 0.62 |
